Weekly high-dose 5-fluorouracil as 24-h infusion and folinic acid (AIO) plus irinotecan as second- and third-line treatment in patients with colorectal cancer pre-treated with AIO plus oxaliplatin.

Felix Stickel; Barbara Jüngert; Valeska Brueckl; Iveta Schirner; Wolfgang M Brueckl; Gudrun Männlein; Janice Hegewald; Steffen Mühldorfer; Birgit Bittorf; Werner Hohenberger; Eckhart G Hahn; Axel Wein

doi:10.1097/01.cad.0000094781.62385.a1

Weekly high-dose 5-fluorouracil as 24-h infusion and folinic acid (AIO) plus irinotecan as second- and third-line treatment in patients with colorectal cancer pre-treated with AIO plus oxaliplatin.

Felix Stickel, Barbara Jüngert, Valeska Brueckl, Iveta Schirner, Wolfgang M Brueckl, Gudrun Männlein, Janice Hegewald, Steffen Mühldorfer, Birgit Bittorf, Werner Hohenberger, Eckhart G Hahn, Axel Wein

Department of Internal Medicine III, Division of Respiratory Medicine, Allergology and Sleep Medicine

Research output: Contribution to journal › Original Article › peer-review

14 Citations (Web of Science)

Original language	English
Pages (from-to)	745-749
Journal	ANTI-CANCER DRUGS
Volume	14
Issue number	9
DOIs	https://doi.org/10.1097/01.cad.0000094781.62385.a1
Publication status	Published - 2003

Keywords

LIVER METASTASES
THERAPY

Access to Document

10.1097/01.cad.0000094781.62385.a1

Cite this

Stickel, F., Jüngert, B., Brueckl, V., Schirner, I., Brueckl, W. M., Männlein, G., Hegewald, J., Mühldorfer, S., Bittorf, B., Hohenberger, W., Hahn, E. G., & Wein, A. (2003). Weekly high-dose 5-fluorouracil as 24-h infusion and folinic acid (AIO) plus irinotecan as second- and third-line treatment in patients with colorectal cancer pre-treated with AIO plus oxaliplatin. ANTI-CANCER DRUGS, 14(9), 745-749. https://doi.org/10.1097/01.cad.0000094781.62385.a1

@article{5cc4e5e337ee45f7b802e2a15efc8869,

title = "Weekly high-dose 5-fluorouracil as 24-h infusion and folinic acid (AIO) plus irinotecan as second- and third-line treatment in patients with colorectal cancer pre-treated with AIO plus oxaliplatin.",

keywords = "LIVER METASTASES, THERAPY",

author = "Felix Stickel and Barbara J{\"u}ngert and Valeska Brueckl and Iveta Schirner and Brueckl, {Wolfgang M} and Gudrun M{\"a}nnlein and Janice Hegewald and Steffen M{\"u}hldorfer and Birgit Bittorf and Werner Hohenberger and Hahn, {Eckhart G} and Axel Wein",

year = "2003",

doi = "10.1097/01.cad.0000094781.62385.a1",

language = "English",

volume = "14",

pages = "745--749",

journal = "ANTI-CANCER DRUGS",

issn = "0959-4973",

publisher = "Lippincott Williams & Wilkins ",

number = "9",

}

Stickel, F, Jüngert, B, Brueckl, V, Schirner, I, Brueckl, WM, Männlein, G, Hegewald, J, Mühldorfer, S, Bittorf, B, Hohenberger, W, Hahn, EG & Wein, A 2003, 'Weekly high-dose 5-fluorouracil as 24-h infusion and folinic acid (AIO) plus irinotecan as second- and third-line treatment in patients with colorectal cancer pre-treated with AIO plus oxaliplatin.', ANTI-CANCER DRUGS, vol. 14, no. 9, pp. 745-749. https://doi.org/10.1097/01.cad.0000094781.62385.a1

Weekly high-dose 5-fluorouracil as 24-h infusion and folinic acid (AIO) plus irinotecan as second- and third-line treatment in patients with colorectal cancer pre-treated with AIO plus oxaliplatin. / Stickel, Felix; Jüngert, Barbara; Brueckl, Valeska et al.
In: ANTI-CANCER DRUGS, Vol. 14, No. 9, 2003, p. 745-749.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Weekly high-dose 5-fluorouracil as 24-h infusion and folinic acid (AIO) plus irinotecan as second- and third-line treatment in patients with colorectal cancer pre-treated with AIO plus oxaliplatin.

AU - Stickel, Felix

AU - Jüngert, Barbara

AU - Brueckl, Valeska

AU - Schirner, Iveta

AU - Brueckl, Wolfgang M

AU - Männlein, Gudrun

AU - Hegewald, Janice

AU - Mühldorfer, Steffen

AU - Bittorf, Birgit

AU - Hohenberger, Werner

AU - Hahn, Eckhart G

AU - Wein, Axel

PY - 2003

Y1 - 2003

KW - LIVER METASTASES

KW - THERAPY

U2 - 10.1097/01.cad.0000094781.62385.a1

DO - 10.1097/01.cad.0000094781.62385.a1

M3 - Original Article

C2 - 14551509

SN - 0959-4973

VL - 14

SP - 745

EP - 749

JO - ANTI-CANCER DRUGS

JF - ANTI-CANCER DRUGS

IS - 9

ER -